Global Gene Therapy On Cardiovascular Disease Market Growth (Status and Outlook) 2025-2031

May 2025 | 137 pages | ID: G270D7ED197AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.

The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.

Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.

LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.

This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Analog Vacuum Regulator
• Digital Vacuum Regulator

Segmentation by Application:

• Clinically
• Surgical

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Ohio Medical
• Amico
• Precision Medical
• Air Liquid Healthcare
• Integral
• Allied Healthcare Products
• Shanghai Amcaremed Technology
• Acare
• Hersill

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Vacuum Regulator market?

What factors are driving Medical Vacuum Regulator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Vacuum Regulator market opportunities vary by end market size?

How does Medical Vacuum Regulator break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size (2020-2031)
  2.1.2 Gene Therapy On Cardiovascular Disease Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Gene Therapy On Cardiovascular Disease by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy On Cardiovascular Disease Segment by Type
  2.2.1 Viral Gene Therapy
  2.2.2 Non-Viral Gene Therapy
2.3 Gene Therapy On Cardiovascular Disease Market Size by Type
  2.3.1 Gene Therapy On Cardiovascular Disease Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy On Cardiovascular Disease Segment by Application
  2.4.1 Heart Disease
  2.4.2 Vascular Disease
2.5 Gene Therapy On Cardiovascular Disease Market Size by Application
  2.5.1 Gene Therapy On Cardiovascular Disease Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2020-2025)

3 GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET SIZE BY PLAYER

3.1 Gene Therapy On Cardiovascular Disease Market Size Market Share by Player
  3.1.1 Global Gene Therapy On Cardiovascular Disease Revenue by Player (2020-2025)
  3.1.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy On Cardiovascular Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENE THERAPY ON CARDIOVASCULAR DISEASE BY REGION

4.1 Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025)
4.2 Global Gene Therapy On Cardiovascular Disease Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy On Cardiovascular Disease Market Size Growth (2020-2025)
4.4 APAC Gene Therapy On Cardiovascular Disease Market Size Growth (2020-2025)
4.5 Europe Gene Therapy On Cardiovascular Disease Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025)
5.2 Americas Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025)
5.3 Americas Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025)
6.2 APAC Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025)
6.3 APAC Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025)
7.2 Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025)
7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gene Therapy On Cardiovascular Disease by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GENE THERAPY ON CARDIOVASCULAR DISEASE MARKET FORECAST

10.1 Global Gene Therapy On Cardiovascular Disease Forecast by Region (2026-2031)
  10.1.1 Global Gene Therapy On Cardiovascular Disease Forecast by Region (2026-2031)
  10.1.2 Americas Gene Therapy On Cardiovascular Disease Forecast
  10.1.3 APAC Gene Therapy On Cardiovascular Disease Forecast
  10.1.4 Europe Gene Therapy On Cardiovascular Disease Forecast
  10.1.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Forecast
10.2 Americas Gene Therapy On Cardiovascular Disease Forecast by Country (2026-2031)
  10.2.1 United States Market Gene Therapy On Cardiovascular Disease Forecast
  10.2.2 Canada Market Gene Therapy On Cardiovascular Disease Forecast
  10.2.3 Mexico Market Gene Therapy On Cardiovascular Disease Forecast
  10.2.4 Brazil Market Gene Therapy On Cardiovascular Disease Forecast
10.3 APAC Gene Therapy On Cardiovascular Disease Forecast by Region (2026-2031)
  10.3.1 China Gene Therapy On Cardiovascular Disease Market Forecast
  10.3.2 Japan Market Gene Therapy On Cardiovascular Disease Forecast
  10.3.3 Korea Market Gene Therapy On Cardiovascular Disease Forecast
  10.3.4 Southeast Asia Market Gene Therapy On Cardiovascular Disease Forecast
  10.3.5 India Market Gene Therapy On Cardiovascular Disease Forecast
  10.3.6 Australia Market Gene Therapy On Cardiovascular Disease Forecast
10.4 Europe Gene Therapy On Cardiovascular Disease Forecast by Country (2026-2031)
  10.4.1 Germany Market Gene Therapy On Cardiovascular Disease Forecast
  10.4.2 France Market Gene Therapy On Cardiovascular Disease Forecast
  10.4.3 UK Market Gene Therapy On Cardiovascular Disease Forecast
  10.4.4 Italy Market Gene Therapy On Cardiovascular Disease Forecast
  10.4.5 Russia Market Gene Therapy On Cardiovascular Disease Forecast
10.5 Middle East & Africa Gene Therapy On Cardiovascular Disease Forecast by Region (2026-2031)
  10.5.1 Egypt Market Gene Therapy On Cardiovascular Disease Forecast
  10.5.2 South Africa Market Gene Therapy On Cardiovascular Disease Forecast
  10.5.3 Israel Market Gene Therapy On Cardiovascular Disease Forecast
  10.5.4 Turkey Market Gene Therapy On Cardiovascular Disease Forecast
10.6 Global Gene Therapy On Cardiovascular Disease Forecast by Type (2026-2031)
10.7 Global Gene Therapy On Cardiovascular Disease Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Gene Therapy On Cardiovascular Disease Forecast

11 KEY PLAYERS ANALYSIS

11.1 Renovacor
  11.1.1 Renovacor Company Information
  11.1.2 Renovacor Gene Therapy On Cardiovascular Disease Product Offered
  11.1.3 Renovacor Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Renovacor Main Business Overview
  11.1.5 Renovacor Latest Developments
11.2 Gene Biotherapeutics
  11.2.1 Gene Biotherapeutics Company Information
  11.2.2 Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Offered
  11.2.3 Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Gene Biotherapeutics Main Business Overview
  11.2.5 Gene Biotherapeutics Latest Developments
11.3 AskBio
  11.3.1 AskBio Company Information
  11.3.2 AskBio Gene Therapy On Cardiovascular Disease Product Offered
  11.3.3 AskBio Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AskBio Main Business Overview
  11.3.5 AskBio Latest Developments
11.4 Human Stem Cells Institute
  11.4.1 Human Stem Cells Institute Company Information
  11.4.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offered
  11.4.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Human Stem Cells Institute Main Business Overview
  11.4.5 Human Stem Cells Institute Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis Gene Therapy On Cardiovascular Disease Product Offered
  11.5.3 Novartis Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 Biogen
  11.6.1 Biogen Company Information
  11.6.2 Biogen Gene Therapy On Cardiovascular Disease Product Offered
  11.6.3 Biogen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Biogen Main Business Overview
  11.6.5 Biogen Latest Developments
11.7 Gilead Sciences
  11.7.1 Gilead Sciences Company Information
  11.7.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offered
  11.7.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Gilead Sciences Main Business Overview
  11.7.5 Gilead Sciences Latest Developments
11.8 Sarepta Therapeutics
  11.8.1 Sarepta Therapeutics Company Information
  11.8.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
  11.8.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sarepta Therapeutics Main Business Overview
  11.8.5 Sarepta Therapeutics Latest Developments
11.9 Alnylam Pharmaceuticals
  11.9.1 Alnylam Pharmaceuticals Company Information
  11.9.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offered
  11.9.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Alnylam Pharmaceuticals Main Business Overview
  11.9.5 Alnylam Pharmaceuticals Latest Developments
11.10 Amgen
  11.10.1 Amgen Company Information
  11.10.2 Amgen Gene Therapy On Cardiovascular Disease Product Offered
  11.10.3 Amgen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Amgen Main Business Overview
  11.10.5 Amgen Latest Developments
11.11 Spark Therapeutics
  11.11.1 Spark Therapeutics Company Information
  11.11.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
  11.11.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Spark Therapeutics Main Business Overview
  11.11.5 Spark Therapeutics Latest Developments
11.12 Akcea Therapeutics
  11.12.1 Akcea Therapeutics Company Information
  11.12.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
  11.12.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Akcea Therapeutics Main Business Overview
  11.12.5 Akcea Therapeutics Latest Developments
11.13 Sunway Biotech
  11.13.1 Sunway Biotech Company Information
  11.13.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offered
  11.13.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Sunway Biotech Main Business Overview
  11.13.5 Sunway Biotech Latest Developments
11.14 SIBIONO
  11.14.1 SIBIONO Company Information
  11.14.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Offered
  11.14.3 SIBIONO Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 SIBIONO Main Business Overview
  11.14.5 SIBIONO Latest Developments
11.15 AnGes
  11.15.1 AnGes Company Information
  11.15.2 AnGes Gene Therapy On Cardiovascular Disease Product Offered
  11.15.3 AnGes Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 AnGes Main Business Overview
  11.15.5 AnGes Latest Developments
11.16 Orchard Therapeutics
  11.16.1 Orchard Therapeutics Company Information
  11.16.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
  11.16.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Orchard Therapeutics Main Business Overview
  11.16.5 Orchard Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Gene Therapy On Cardiovascular Disease Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy On Cardiovascular Disease Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Viral Gene Therapy
Table 4. Major Players of Non-Viral Gene Therapy
Table 5. Gene Therapy On Cardiovascular Disease Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy On Cardiovascular Disease Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy On Cardiovascular Disease Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy On Cardiovascular Disease Key Players Head office and Products Offered
Table 14. Gene Therapy On Cardiovascular Disease Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy On Cardiovascular Disease Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy On Cardiovascular Disease Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy On Cardiovascular Disease
Table 39. Key Market Challenges & Risks of Gene Therapy On Cardiovascular Disease
Table 40. Key Industry Trends of Gene Therapy On Cardiovascular Disease
Table 41. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Renovacor Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 46. Renovacor Gene Therapy On Cardiovascular Disease Product Offered
Table 47. Renovacor Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Renovacor Main Business
Table 49. Renovacor Latest Developments
Table 50. Gene Biotherapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 51. Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 52. Gene Biotherapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Gene Biotherapeutics Main Business
Table 54. Gene Biotherapeutics Latest Developments
Table 55. AskBio Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 56. AskBio Gene Therapy On Cardiovascular Disease Product Offered
Table 57. AskBio Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. AskBio Main Business
Table 59. AskBio Latest Developments
Table 60. Human Stem Cells Institute Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 61. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offered
Table 62. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Human Stem Cells Institute Main Business
Table 64. Human Stem Cells Institute Latest Developments
Table 65. Novartis Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 66. Novartis Gene Therapy On Cardiovascular Disease Product Offered
Table 67. Novartis Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Biogen Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 71. Biogen Gene Therapy On Cardiovascular Disease Product Offered
Table 72. Biogen Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Biogen Main Business
Table 74. Biogen Latest Developments
Table 75. Gilead Sciences Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 76. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offered
Table 77. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Gilead Sciences Main Business
Table 79. Gilead Sciences Latest Developments
Table 80. Sarepta Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 81. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 82. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Sarepta Therapeutics Main Business
Table 84. Sarepta Therapeutics Latest Developments
Table 85. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 86. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offered
Table 87. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Alnylam Pharmaceuticals Main Business
Table 89. Alnylam Pharmaceuticals Latest Developments
Table 90. Amgen Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 91. Amgen Gene Therapy On Cardiovascular Disease Product Offered
Table 92. Amgen Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Amgen Main Business
Table 94. Amgen Latest Developments
Table 95. Spark Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 96. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 97. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Spark Therapeutics Main Business
Table 99. Spark Therapeutics Latest Developments
Table 100. Akcea Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 101. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 102. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Akcea Therapeutics Main Business
Table 104. Akcea Therapeutics Latest Developments
Table 105. Sunway Biotech Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 106. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offered
Table 107. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Sunway Biotech Main Business
Table 109. Sunway Biotech Latest Developments
Table 110. SIBIONO Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 111. SIBIONO Gene Therapy On Cardiovascular Disease Product Offered
Table 112. SIBIONO Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. SIBIONO Main Business
Table 114. SIBIONO Latest Developments
Table 115. AnGes Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 116. AnGes Gene Therapy On Cardiovascular Disease Product Offered
Table 117. AnGes Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. AnGes Main Business
Table 119. AnGes Latest Developments
Table 120. Orchard Therapeutics Details, Company Type, Gene Therapy On Cardiovascular Disease Area Served and Its Competitors
Table 121. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offered
Table 122. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Orchard Therapeutics Main Business
Table 124. Orchard Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Gene Therapy On Cardiovascular Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy On Cardiovascular Disease Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy On Cardiovascular Disease Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy On Cardiovascular Disease Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy On Cardiovascular Disease Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type in 2024
Figure 10. Gene Therapy On Cardiovascular Disease in Heart Disease
Figure 11. Global Gene Therapy On Cardiovascular Disease Market: Heart Disease (2020-2025) & ($ millions)
Figure 12. Gene Therapy On Cardiovascular Disease in Vascular Disease
Figure 13. Global Gene Therapy On Cardiovascular Disease Market: Vascular Disease (2020-2025) & ($ millions)
Figure 14. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Application in 2024
Figure 15. Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Player in 2024
Figure 16. Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2020-2025)
Figure 17. Americas Gene Therapy On Cardiovascular Disease Market Size 2020-2025 ($ millions)
Figure 18. APAC Gene Therapy On Cardiovascular Disease Market Size 2020-2025 ($ millions)
Figure 19. Europe Gene Therapy On Cardiovascular Disease Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size 2020-2025 ($ millions)
Figure 21. Americas Gene Therapy On Cardiovascular Disease Value Market Share by Country in 2024
Figure 22. United States Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Region in 2024
Figure 27. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2020-2025)
Figure 28. APAC Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2020-2025)
Figure 29. China Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 33. India Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Country in 2024
Figure 36. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2020-2025)
Figure 37. Europe Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2020-2025)
Figure 38. Germany Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 39. France Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Gene Therapy On Cardiovascular Disease Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 52. APAC Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 53. Europe Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 55. United States Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 56. Canada Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 57. Mexico Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 58. Brazil Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 59. China Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 60. Japan Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 61. Korea Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 63. India Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 64. Australia Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 65. Germany Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 66. France Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 67. UK Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 68. Italy Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 69. Russia Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 70. Egypt Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 71. South Africa Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 72. Israel Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 73. Turkey Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)
Figure 74. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Gene Therapy On Cardiovascular Disease Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Gene Therapy On Cardiovascular Disease Market Size 2026-2031 ($ millions)